Ph II Gemcitabine, Erlotinib, and Gemcitabine With Erlotinib/Elderly Patients W/ IIIB/IV NSCLC
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Thomas E Stinchcombe, MD
UNC Lineberger Comprehensive Cancer Center
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
11 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Highlands Oncology Group - Fayetteville
Fayetteville, Arkansas, United States
- Summit Cancer Care
Savannah, Georgia, United States
- Evanston Hospital
Evanston, Illinois, United States
- Hackensack University Medical Center Cancer Center
Hackensack, New Jersey, United States
- Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill
Chapel Hill, North Carolina, United States
- Blumenthal Cancer Center at Carolinas Medical Center
Charlotte, North Carolina, United States
- Batte Cancer Center at Northeast Medical Center
Concord, North Carolina, United States
- Cape Fear Valley Medical Center Cancer Center
Fayetteville, North Carolina, United States
- Rex Cancer Center at Rex Hospital
Raleigh, North Carolina, United States
- Kingsport Hematology-Oncology Associates
Kingsport, Tennessee, United States
- University of Tennessee Cancer Institute - Memphis
Memphis, Tennessee, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Mar 2006
- Primary completion
- 30 Sept 2014
- Completion
- 31 Oct 2014
- Last update posted
- 24 Apr 2017
- Registered enrollment
- 147
- Registry id
- NCT00283244
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.